Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT05544149Phase 2Unknown
TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors
SCLC,Extensive Stage
PrincipalinvestigatorStart date: 2022-09-01
NCT05387044Phase 2Unknown
SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors
NSCLC Stage IV
PrincipalinvestigatorStart date: 2022-05-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Department of Thoracic Radiotherapy, Zhejiang Cancer Hospital

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT05544149Phase 2PrincipalInvestigator

TRT for ES-SCLC After First Line Treatment With Immune Checkpoint Inhibitors

SCLC,Extensive Stage
Unknown
NCT05387044Phase 2PrincipalInvestigator

SBRT for Oligoprogressive NSCLC After First Line Treatment With Immune Checkpoint Inhibitors

NSCLC Stage IV
Unknown

All 2 trials loaded